glp 1 ag May Patients Receiving GLP-1 Agonists Be at Lower Risk of Prostate Cancer Aggressiveness and Progression? GLP1 Receptor Agonists—Effects beyond Obesity

Nonhum Primates Biomed Res

Tirzepatide carries FDA-documented side effects reflecting its potent mechanism: nausea, vomiting, diarrhea, and constipation occur in 2560% of patients, typically early and dose-dependent

Wiley Interdiscip Rev Dev Biol 4(3):215266 Presta M et al (2005) Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

Until then, the most accurate answer is: Retatrutide is the higher-upside candidate, while CagriSema is the more incremental combination strategy

Further clinical studies are needed to validate the causal relationship between prolactin and obesity, and to explore the specific mechanisms by which prolactin levels and rhythms are regulated to improve obesity and metabolic health